Back
Novo Nordisk A/S Stock Predictions
Buy
60
NVO
Novo Nordisk A/S
Last Price:
131.88
Seasonality Move:
4.24%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk A/S Stock Forecast
- Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 20.3% based on the past 43 years of stock performance.
- Novo Nordisk A/S has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
-
Is Novo Nordisk A/S Stock Undervalued?
The current Novo Nordisk A/S [NVO] share price is $131.89. The Score for NVO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal. - NVO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
- Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 20.3% based on the past 43 years of stock performance.
Novo Nordisk A/S Stock Rating
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S overpriced?
- Novo Nordisk A/S has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
138.28
52-Week Low:
75.56
Prediction Charts
Market Cap:
587.55B
Price in USD:
131.89
Volume:
2.59M
Beta:
0.49
Technical Analysis
SMA50:
128.16
SMA100:
121.15
SMA200:
108.64
52-Wk Change:
57.86%
Stock Predictions
-
Is Novo Nordisk A/S stock public?
Yes, Novo Nordisk A/S is a publicly traded company. -
What is the Novo Nordisk A/S stock quote today?
The Novo Nordisk A/S stock price is 131.89 USD today. -
How to buy Novo Nordisk A/S stock online?
You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 128.05 | 128.31 | 130.46 | 127.49 |
May-1 | 127.80 | 129.21 | 130.13 | 127.50 |
May-2 | 127.94 | 124.02 | 127.94 | 123.83 |
May-3 | 122.92 | 123.05 | 123.77 | 121.29 |
May-6 | 122.00 | 124.59 | 124.64 | 121.78 |
May-7 | 126.65 | 127.29 | 127.80 | 126.38 |
May-8 | 127.51 | 126.69 | 128.43 | 126.62 |
May-9 | 127.44 | 128.66 | 128.80 | 126.94 |
May-10 | 129.09 | 128.42 | 130.27 | 128.33 |
May-13 | 131.47 | 132.41 | 133.50 | 130.40 |
May-14 | 132.18 | 132.92 | 133.00 | 131.30 |
May-15 | 132.95 | 134.66 | 134.79 | 132.90 |
May-16 | 133.13 | 133.04 | 133.67 | 132.48 |
May-17 | 131.94 | 131.89 | 132.09 | 130.85 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.78 per share.
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.